Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LGR6+ stem cells may improve bone healing.

Foxn1 is essential for hair pigmentation by directing pigment transfer to hair cells.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

The GPRC6A-Duox1 axis helps control hair growth and loss by affecting hydrogen peroxide production.

An 8-year-old with scalp fungus was successfully treated with Terbinafine, preventing hair loss and spread.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

SOX11 and SOX4 help skin cells act like embryonic cells to heal wounds in mice.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Medium lipophilic substances penetrate skin best, and adding ethanol can increase delivery to hair follicles.

FGF-5 promotes Cashmere goat hair growth by increasing keratin genes and reducing certain LncRNA and target genes.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.